ロード中...
Assessing quality of life on the day of chemotherapy administration underestimates patients’ true symptom burden
BACKGROUND: In chemotherapy trials quality of life (QOL) is assessed mostly at the days of chemotherapy administration (i.e. event-driven) during treatment and follows fixed time intervals in the aftercare phase (i.e. time-driven). Specific QOL impairments and treatment side-effects are known to be...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4198707/ https://ncbi.nlm.nih.gov/pubmed/25305067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-758 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|